Narrative Update: Bodal Chemicals Analyst Price Target Revision
Analysts have maintained their price target for Bodal Chemicals at ₹107.00. They stated that minor adjustments to the discount rate and forward-looking estimates were not significant enough to warrant a change in valuation.
What's in the News
- Bodal Chemicals Limited has scheduled a Board Meeting on November 12, 2025, to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, as well as to discuss other business. (Company filing)
- At the Annual General Meeting held on September 26, 2025, Bodal Chemicals approved the appointment of M/s. BNP Sand Associates LLP as Statutory Auditor, following the merger with M/s. Naresh J, Patel & Co. (Company announcement)
Valuation Changes
- Consensus Analyst Price Target remains unchanged at ₹107.00.
- Discount Rate has decreased slightly from 17.09% to 16.68%.
- Revenue Growth projection is steady at 13.66%.
- Net Profit Margin estimate remains nearly flat at 5.79%.
- Future P/E has edged down marginally from 13.98x to 13.83x.
Have other thoughts on Bodal Chemicals?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.